Member Info for violindog

Well , the SP is rising after those trades …so fingers crossed something is afoot 🤞

Moon…let’s hope so as this supply never ends 😬.. but that was a true whopper so perhaps it may be the last?

Odd time to sell as management allude to potential deals. Unless it’s a forced sell from a fund ?

Aqua…what an awful post !

There’s a pattern, the SP reaches around 60 p , falls back to the low 50s and repeats.

Loads of small trades again …and the SP falls !

Most of the advertised trades are sub 5k .. some are tiny and yet we are down 5% …Is there any demand for MKA currently?

Just need it reflected in the SP 🤞

Hopefully on the road to £1 😁

B99, as a chartist what are your thoughts re SP , thanks

But what is the “message” .. if they were negotiating with potential partners would they need to bang the drum ? More like a fundraising is being prepared.

Perhaps the market is spooked by the share price reaction of Faron pharmaceuticals. They are fundraising to get their lead product through a FDA stage 3 trial.

No matter how amazing the science AIM biotechnology companies are totally reliant on funding and nothing else seems to budge the share price.

The mood music from Scancell sounds very similar to the statement by Faron. We need that deal ASAP .

“Chairman statement by Faron”

"The Board has carefully considered a range of financing alternatives, including non-dilutive funding, debt instruments and equity-linked structures to fund the development of bexmarilimab. Having taken into account the Company's development stage, market conditions and the importance of reaching a flexible balance sheet, we have concluded that equity financing by way of a rights offering is the most appropriate and prudent course of action at this time for the Company and its shareholders.”

CFO puts out a very positive video 2 days ago related to milestones…. And we are down 8.3% !!!

Fundraising??

Interesting articles Vascular. Perhaps with the current trade relations between the USA and China , Chinese pharma may look more towards the UK biotechnology sector for deals? Scancell would certainly fit the bill !

From the results : …..“Cash runway to H2 2026, beyond near-term clinical and regulatory milestones and with further upside opportunities.”

We have discussed the fact that any near term milestone payments from Genmab certainly won’t cover the phase 3 trial . A strong financial base would certainly help in any negotiations as Scancell won’t look distressed. So , including this month , we have 5 to go before we enter H2. Something has to give soon …and the options are… partner, bid, or fundraise. Left field …a bid from a Chinese pharma or even the Australian gov funding development by taking a strategic stake, a bit like the USA gov investing in critical mineral companies. Or is the “off the shelf vaccine” going to stay “on the shelf” 🤣 Interest and some SP momentum must surely gather pace soon 🤞

+4 to -3 %. Disappointing to say the least ! Unless we are listed in the USA this is going nowhere unless we get a surprise bid .

This corrupt Government will side with Moderna…the writing is on the wall and they have contracts as per Burbles post.

The worry is the advantage of Scib will be eroded as it’s already been stated that AI will dramatically reduce the time it takes to manufacture a personalised vaccine.

We need to get a deal and keep up with Moderna’s momentum as Scib still has the edge and advantage.

….we need to get that deal over the line ASAP

..needs a USA listing..simple

Wild, doubt very much from this Government !